Differential patient travel burden to pediatric atopic dermatitis clinical trial sites - 19/02/25
Doi : 10.1016/j.jaad.2024.10.061
Joseph Masison, BS a, Eric J. Beltrami, MD b, Christian Gronbeck, MD c, Hao Feng, MD, MHS c, ⁎ 
a University of Connecticut School of Medicine, Farmington, Connecticut
b Department of Dermatology, Boston University Medical Center, Boston, Massachusetts
c Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut
∗Correspondence to: Hao Feng, MD, MHS, Department of Dermatology, University of Connecticut Health Center, 21 South Road, 2nd Floor, Farmington, CT 06032Department of DermatologyUniversity of Connecticut Health Center21 South Road, 2nd FloorFarmingtonCT06032
Key words : access, clinical trials, clinical trial sites, demographics, disparities, distance, pediatric atopic dermatitis, travel
| Funding sources: None. |
|
| IRB approval status: This study received an exemption from the University of Connecticut Health Center Institutional Review Board. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 92 - N° 3
P. 596-598 - mars 2025 Retour au numéro
Article précédent
- Cross-sectional cost analysis of finasteride for androgenetic alopecia via direct-to-consumer pharmacies compared with online wholesale pharmacies
- Zachary Buxo, Joseph W. Fakhoury
- Characterizing narrowband UVB post-treatment erythema: Standardization of a burn
- Megan Lau, Niki Cohen, Arielle Nagler, Steven Friedman, Soutrik Mandal, John G. Zampella
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?